Invention Grant
- Patent Title: Extended dicer substrate agents and methods for the specific inhibition of gene expression
-
Application No.: US17407930Application Date: 2021-08-20
-
Publication No.: US11414664B2Publication Date: 2022-08-16
- Inventor: Bob Dale Brown
- Applicant: Dicerna Pharmaceuticals, Inc.
- Applicant Address: US MA Lexington
- Assignee: Dicerna Pharmaceuticals, Inc.
- Current Assignee: Dicerna Pharmaceuticals, Inc.
- Current Assignee Address: US MA Lexington
- Agency: MH2 Technology Law Group, LLP
- Agent Byron V. Olsen
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C07H21/02 ; C12N15/113 ; A61K31/713 ; C12N15/11

Abstract:
The invention provides compositions and methods for reducing expression of a target gene in a cell, involving contacting a cell with an isolated double stranded nucleic acid (dsNA) in an amount effective to reduce expression of a target gene in a cell. The dsNAs of the invention possess a single stranded extension (in most embodiments, the single stranded extension comprises at least one modified nucleotide and/or phosphate back bone modification). Such single stranded extended Dicer-substrate siRNAs (DsiRNAs) were demonstrated to be effective RNA inhibitory agents compared to corresponding double stranded DsiRNAs.
Public/Granted literature
- US20210403909A1 EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION Public/Granted day:2021-12-30
Information query